Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
Main Authors: | Bellmunt, J. (Author), Comperat, E. (Author), De Santis, M. (Author), ESMO Guidelines Committee (Author), Gillessen, S. (Author), Huddart, R. (Author), Loriot, Y. (Author), Necchi, A. (Author), Powles, T. (Author), Ravaud, A. (Author), Shariat, S.F (Author), Szabados, B. (Author), Valderrama, B.P (Author), van der Heijden, M.S (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier Ltd
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Cystitis cystica and cystitis glandularis: its relationship to the development of urothelial bladder cancer
by: М. V. Kovylina, et al.
Published: (2015-12-01) -
Targeted Molecular Therapeutics for Bladder Cancer—A New Option beyond the Mixed Fortunes of Immune Checkpoint Inhibitors?
by: Olga Bednova, et al.
Published: (2020-10-01) -
A Rare Case of Sensory Neuropathy Associated with Transitional Cell Carcinoma of the Bladder
by: Sujitha Ketineni, et al.
Published: (2020-11-01) -
Phase I/II Pilot Study of Intravesical Apaziquone (EO9) for Superficial Bladder Cancer
by: Puri, Rajiv, et al.
Published: (2009) -
Prostatic Inflammation is Determinant for Prostate Overgrowth and Luts Severity in Men with Metabolic Syndrome: Highlights from Two Recently Published Multicentre Studies
by: Mauro Gacci, et al.
Published: (2013-12-01)